Associate Director
Novartis, Massachusetts, United States
Douglas Auld, Ph.D. is an Associate Director working at the Novartis Institutes for Biomedical Research (NIBR) in Cambridge, Mass. His post-doctoral training was at M.I.T. with Prof. Paul Schimmel. Following his post-doc., Dr. Auld worked at Pharmacopeia in Princeton NJ where he led drug discovery efforts using encoded combinatorial libraries. In 2004 Dr. Auld was hired to help start the NIH Chemical Genomics Center as part of the NIH Roadmap Initiative. At NIH his group was involved with profiling the PubChem library against a wide range of biochemical and cell-based assays related to both rare and common diseases and applied expertise in both biology and chemistry to develop high quality chemical probes. Dr. Auld joined NIBR in 2010. Current efforts aim to enable lead discovery by integrating innovative screening approaches including the use of primary cell types, exploring new reporter systems, and high content cellular analysis. Dr. Auld also manages a lab at NIBR that performs collaboratons with academic investigators. Dr. Auld has over one hundred publications in the areas of drug discovery, assay development, and chemical biology.
Disclosure information not submitted.
Saturday, February 5, 2022
8:15 AM – 5:00 PM
Tuesday, February 8, 2022
4:00 PM – 5:30 PM